国产av不卡一区二区_欧美xxxx做受欧美_成年人看的毛片_亚洲第一天堂在线观看_亚洲午夜精品久久久中文影院av_8x8ⅹ国产精品一区二区二区_久久精品国产sm调教网站演员_亚洲av综合色区无码一二三区_成人免费激情视频_国产九九九视频

• Search
• HOME
• CHINA
• WORLD
• BUSINESS
• LIFESTYLE
• CULTURE
• TRAVEL
• VIDEO
• SPORTS
• OPINION
• REGIONAL
• NEWSPAPER
• MOBILE

Global EditionASIA 中文雙語Fran?ais

1. Home
2. World
/ Europe

CureVac fails in COVID-19 vaccine trial with 47% efficacy

By Ouyang Xueyan | chinadaily.com.cn | Updated: 2021-06-18 00:04

Share

Share - WeChat

CLOSE

German biotech CureVac's COVID-19 vaccine has come out of a late-stage trial with 47 percent efficacy but the health ministry has said this will not impact the country's vaccination rollout.

Photos

US Justice Department starts releasing Epstein files

Ties with Beijing underscored in Putin remarks

Winter storm batters western US, cuts power to around 750,000 customers

Japan's security moves draw sharp criticism

China offers to resolve Thailand-Cambodia rift

NHS on life support as strikes continue

Most Viewed in 24 Hours

World in Focus

Cultural restoration

Across Asia +

Match online

Himalayas warming 50 percent faster than global average: Study

Special Coverage +

2025 A Date with China

GMD SCO Summit Cities Tianjin

Friends Afar +

Blogger aims to bridge France, China links

Ties That Bind +

Vital pass to boost China-Pakistan trade

English

中文

Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

License for publishing multimedia online 0108263

Registration Number: 130349

About China Daily

Advertise on Site

Contact Us

Job Offer

Expat Employment

FOLLOW US